We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLB icon
1726
Core Laboratories
CLB
$538M
$19K ﹤0.01%
99
-7
-7% -$1.32K
DKS icon
1727
Dick's Sporting Goods
DKS
$18.4B
$19K ﹤0.01%
352
-3,275
-90% -$177K
DOC icon
1728
Healthpeak Properties
DOC
$15.4B
$19K ﹤0.01%
549
-580
-51% -$20K
ILF icon
1729
iShares Latin America 40 ETF
ILF
$3.77B
$19K ﹤0.01%
520
– –
MKL icon
1730
Markel Group
MKL
$25B
$19K ﹤0.01%
33
– –
PRTA icon
1731
Prothena Corp
PRTA
$458M
$19K ﹤0.01%
520
– –
PXH icon
1732
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.9B
$19K ﹤0.01%
1,000
– –
AXE
1733
DELISTED
Anixter International Inc
AXE
$19K ﹤0.01%
196
-126
-39% -$12.3K
RGC
1734
DELISTED
Regal Entertainment Group
RGC
$19K ﹤0.01%
1,051
-41
-4% -$788
HTS
1735
DELISTED
HATTERAS FINANCIAL CORP
HTS
$19K ﹤0.01%
1,065
-10,721
-91% -$200K
BBEP
1736
DELISTED
BREITBURN ENERGY PARTNERS LP COM UNITS RPTNG LTD PRTNRSHIP
BBEP
$19K ﹤0.01%
1,000
– –
QIHU
1737
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
$19K ﹤0.01%
+200
New +$19.9K
MNR
1738
DELISTED
Monmouth Real Estate Investment Corp
MNR
$19K ﹤0.01%
2,000
– –
ACTG icon
1739
Acacia Research
ACTG
$450M
$18K ﹤0.01%
1,222
-10
-0.8% -$145
CAR icon
1740
Avis
CAR
$5.63B
$18K ﹤0.01%
377
– –
NHI icon
1741
National Health Investors
NHI
$3.9B
$18K ﹤0.01%
300
– –
NVEC icon
1742
NVE Corp
NVEC
$569M
$18K ﹤0.01%
325
– –
USO icon
1743
United States Oil Fund
USO
$2.27B
$18K ﹤0.01%
+63
New +$17.8K
JBTM
1744
JBT Marel
JBTM
$7.14B
$18K ﹤0.01%
613
– –
VSB
1745
DELISTED
VANTAGESOUTH BANCHARES, INC
VSB
$18K ﹤0.01%
2,600
– –
DCI icon
1746
Donaldson
DCI
$10.8B
$17K ﹤0.01%
405
-295
-42% -$12.4K
ENOV icon
1747
Enovis
ENOV
$1.56B
$17K ﹤0.01%
145
– –
EUO icon
1748
ProShares UltraShort Euro
EUO
$35.6M
$17K ﹤0.01%
1,020
– –
SDS icon
1749
ProShares UltraShort S&P500
SDS
$424M
$17K ﹤0.01%
6
– –
VIVS
1750
VivoSim Labs
VIVS
$1.46M
$17K ﹤0.01%
9
– –
68 69
70
71 72

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.